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Abstract  Coagulase-negative  staphylococci  (CoNS)  are  among  the  main  causative  agents  of
bacteremia.  Staphylococcus  epidermidis  and  Staphylococcus  haemolyticus  are  the  CoNS  species
most frequently  isolated.  These  species  are  often  associated  with  infections  in  immunocompro-
mised patients  who  have  a  medical  device  implant.  Methicillin  resistance  was  ﬁrst  described
in Staphylococcus  aureus;  it  has  also  been  reported  in  CoNS  species.  Methicillin  resistance
is conferred  by  expression  of  the  mecA  gene,  contained  within  the  staphylococcal  cassette
chromosome  (SCCmec).  mecA  gene  codes  for  the  PBP2a  protein  which  shows  poor  binding  to
beta-lactam  antibiotics,  so  methicillin-resistant  strains  are  resistant  to  beta-lactams.  The  pres-
ence of  SCCmec  in  CoNS  species  complicates  infections  caused  by  these  organisms,  since  it
confers resistance  to  a  variety  of  antibiotics,  making  treatment  difﬁcult.  This  review  analyzes
the clinical  relevance  of  SCCmec  as  well  as  the  diversity  and  structure  of  elements  present  in
CoNS species.
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Table  1  Structure  of  the  classes  of  mec  complex.
Class  complex  mec  Structure
A  mecI--mecR1--mecA--IS431
B  IS1272--mecR1--mecA--IS431
C  IS431--mecR1--mecA--IS431
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ntroduction
oagulase-negative  staphylococci  (CoNS)  are  key  agents
ontributing  to  infections  in  hospital  environments.  They
re  microorganisms  which  form  part  of  the  normal  skin
nd  mucus  membranes  of  humans,  frequently  isolated  from
atients  with  skin  alterations,  for  instance,  subjects  under-
oing  surgery  or  with  trauma  injuries.  Even  though  they
re  sometimes  considered  as  culture  pollutants  in  clini-
al  bacteriology  laboratories,  they  are  currently  considered
pportunist  pathogens.  They  have  also  been  isolated  from
atients  with  implanted  devices,  such  as  catheters,  pros-
hesis,  derivations,  etc.1--3
In  our  hospital,  studies  on  the  frequency  of  isolated
icroorganisms  in  medical  device-related  infections  have
een  conducted  before.  An  example  of  which  is  a  study
f  the  incidence  of  infections  related  to  central  venous
atheters  (CVC)  in  the  intensive  care  unit  (ICU),  where  a
roup  of  CoNS  was  the  second  most  frequent  group  (8.8%)
n  this  type  of  infection,  only  exceeded  by  Staphylococ-
us  aureus.4 Similarly,  in  a  study  of  infectious  endocarditis
ases,  CoNS  were  the  most  frequent  causative  agent  after
.  aureus.5
In  diverse  studies,  CoNS  have  been  classiﬁed  as  the
ain  causative  agent  of  bacteremia,  causing  around  30%
f  bacteremia  cases  conﬁrmed  by  the  laboratory.6 Within
his  group,  Staphylococcus  epidermidis  and  Staphylococcus
aemolyticus  are  two  CoNS  species  most  frequently  isolated
n  bacteriology  laboratories.7 These  agents  are  the  most
requent  cause  of  bacteremia.  Also,  these  species  present
igh  percentages  of  resistance  to  methicillin,  a  characteris-
ic  which  converts  infections  produced  by  these  species  into
ifﬁcult-to-treat  pathologies.8 In  this  revision,  we  will  dis-
uss  the  clinical  relevance  of  CoNS,  as  well  as  the  genetic
lements  responsible  for  methicillin  resistance  of  CoNS,  par-
icularly  S.  epidermidis  and  S.  haemolyticus.
esistance to methicillin
riginally,  penicillin  was  the  pharmaceutical  of  choice  for
he  treatment  of  infections  caused  by  S.  aureus.  Soon  after,
enicillin-resistant  strains  emerged  due  to  the  acquisition  of
lasmids  which  codify  -lactamases  or  penicillinases.
Methicillin  was  introduced  in  1960:  a  semisynthetic
enicillin  resistant  to  penicillinases.  Nevertheless,  a  year
ater  the  ﬁrst  methicillin-resistant  strains  appeared.  Conse-
uently,  the  term  methicillin-resistant  S.  aureus  was  coined
MRSA).  MRSA  strains  present  an  additional  resistance  to
he  other  -lactamases  antibiotics,  including  cephalosporins
nd  cephemic  agents.9
Resistance  to  methicillin  has  also  been  reported  in
oNS  species  isolated  from  clinical  samples,  with  propor-
ions  even  higher  than  those  reported  in  S.  aureus.  There
re  reports  of  methicillin-resistant  S.  epidermidis  strains
MRSE)  and  methicillin-resistant  S.  haemolyticus  (MRSH),
solated  from  blood,  with  resistance  percentages  over  70%
or  both  species.10--12 Also,  MRSE  and  MRSH  have  been
solated  from  healthy  subjects,  who  are  colonized,  thus
onstituting  an  important  dissemination  source  for  these
pecies.13,14
b
t
gD  mecR1--mecA--IS431
E  mecR1--mecA--IS431
echanism of resistance to -lactams
ntibiotics in methicillin-resistant strains
enicillin  binding  proteins  (PBP)  are  proteins  involved  in  the
etabolism  of  peptidoglycan  of  the  bacterial  cell  wall.15
hen  -lactam  antibiotics  enter  the  active  PBP  site  they
re  bound  covalently,  inhibiting  PBP  function,  hence  the  wall
ynthesis.16
Methicillin-resistant  strains  produce  a  penicillin-binding
rotein,  known  as  PBP2a  or  PBP2′ which  presents  a  low  afﬁn-
ty  to  -lactams.16,17 Therefore,  antibiotics  do  not  remain
ttached  to  PBP2a,  inhibition  of  the  peptidoglycan  synthesis
oes  not  occur,  and  cellular  lysis  is  avoided.16
PBP2a  protein  is  coded  by  the  mecA  gene,  which  is  con-
ained  in  a  mobile  genetic  element  called  staphylococcal
assette  chromosome  mec  (SCCmec).18 SCCmec was  ﬁrst
escribed  in  an  MRSA  strain,  whose  sequencing  set  the  bases
or  the  study  of  SCCmec  basic  characteristics,  as  well  as  its
iversity.
CCmec characteristics
CCmec  is  a  mobile  genetic  element  which  attaches  in  the
acterial  chromosomal  attachment  site  (attBSC),  near  the
rigin  of  replication  in  staphylococci.  Moreover,  SCCmec  pos-
esses  insertion  sequences  (IS)  which  ﬂank  the  mecA  gene,
s  well  as  expression-regulator  genes.  The  set  of  regulator
egions,  insertion  sequences  and  mecA  gene,  are  called  a
ec  complex.  Several  types  of  mec  complexes  have  been
escribed,  depending  on  the  IS  type  present  in  the  mecA
nvironment.  So  far,  ﬁve  types  of  mec  for  S.  aureus  (com-
lex  A  to  E)  have  been  described.19 mec  complex  is  formed
y  mecA, regulator  genes  mecI  and  mecR1, as  well  as  differ-
nt  insertion  sequences  which  may  partially  delete  regulator
enes.
Class  A  mec  complex  is  the  prototype  complex  (Table  1);
t  contains  the  gene  mecA  and  gene  regulators  mecI  and
ecR1.  In  class  B  mec  complex,  the  gene  mecR1  is  partially
eleted  by  the  insertion  of  IS1272; while  in  class  C  mec  com-
lex  the  gene  mecR1  is  partially  deleted  by  the  insertion
f  IS431. Class  C  mec  complex  is  divided  into  two  variants,
1  and  C2,  depending  on  the  orientation  of  IS431. Class  D
ec  complex  presents  the  gene  mecR1  deleted,  but  with-
ut  an  associated  insertion  sequence.  Class  E  mec  complex
s  similar  to  the  latter,  but  with  a  greater  rate  of  mecR1
eletion.19,20 All  complexes  present  an  IS431  subsequent  to
ecA.
Also,  SCCmec possesses  genes  which  codify  for  recom-
inases.  These  recombinases  are  in  charge  of  integrating
he  SCCmec  in  the  bacterial  chromosome.  The  recombinase
ene  groups  are  called  ccr.  There  have  been  three  different
SCCmec in  coagulase  negative  staphylococci  
Table  2  Types  of  ccr  complexes.
Typo  of  ccr  complex  Allotype  of  ccr  genes
Type  1 A1B1
Type  2  A2B2
Type 3  A3B3
Type 4  A4B4
Type 5  C1
Type 6  A5B3
Type 7  A1B6
Type 8  A1B3
Table  3  Types  of  SCCmec  described  for  S.  aureus.
Type  of
SCCmec
Type  of  ccr
complex
Class  of  mec
complex
I  1  B
II 2  A
III 3  A
IV 2  B
V 5  C2
VI 4  B
VII 5  C1
VIII 4  A
IX 1  C2
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types  of  recombinases  to  date:  ccrA,  ccrB,  and  ccrC;  coded
by  the  genes  ccrA, ccrB  and  ccrC, respectively.  There  are
different  allotypes  for  each  one,  depending  on  the  existent
homology  degree.21 Various  allotypes  have  been  identiﬁed
for  recombinase  A  and  B,  while  just  one  allotype  has  been
described  for  recombinase  C.20 They  have  been  classiﬁed
into  eight  different  types  of  complex  ccr  depending  on  exist-
ing  recombinases  and  allotypes  in  the  different  cassettes
(Table  2).
The  regions  located  between  the  complex  ccr,  com-
plex  mec  and  SCCmec  ends  are  known  as  J  regions  (joining
regions),  containing  additional  structures  such  as  plasmids
or  IS,  which  have  the  ability  to  provide  additional  resistance
characteristics.20 The  J1  region  is  located  between  the  right
chromosomic  binding  and  the  ccr  complex.  The  J2  region  is
located  between  the  ccr  complex  and  the  mec  complex.  The
J3  region  is  located  between  the  right  chromosomic  binding
and  the  mec  complex.
SCCmecs are  classiﬁed  into  types  and  subtypes.  SCCmec
types  are  deﬁned  by  the  type  of  mec  complex  and  ccr  com-
plex  present.  Subtypes  are  based  on  differences  present  in  J
regions  (joining  regions)  within  a  SCCmec. These  differences
may  be  plasmids,  insertion  sequences,  or  pseudogenes.19
Thus  far,  eleven  types  of  SCCmec  in  S.  aureus  have  been
described,  based  on  the  combination  in  mec  complex  class
and  ccr  complex  type  (Table  3).21--25SCCmec and resistance to antibiotics
Different  genetic  elements,  such  as  genomic  islands,  bac-
teriophages,  pathogenicity  islands,  chromosomic  cassettes,
f
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lasmids,  insertion  sequences  and  transposons,  intervene
n  the  dissemination  of  resistance  genes  and  staphylococci
irulence.
Insertion  sequences  are  particularly  capable  of  carrying
esistance  determinants  through  homologous  recombina-
ion.  CoNS-resistant  strains  can  function  as  a  deposit  for
ntibiotic-resistant  genes,  which  may  be  transferred  to
icroorganisms,  including  the  S.  aureus  strains.26
With  the  exception  of  mecA, type  I,  IV,  V,  VI  and  VII,
CCmec  do  not  contain  antibiotic-resistant  genes.  How-
ver,  type  II  SCCmec bears  the  Tn554  transposon,  which
ontains  erythromycin-resistant  genes  (ermA) and  specti-
omycin  (spc).  This  SCCmec  also  contains  plasmid  pUB110
ﬂanked  by  a  pair  of  IS431  elements)  which  codiﬁes  resis-
ance  to  kanamycin,  tobramycin  and  bleomycin.
Similarly,  type  III  SCCmec  contains  transposon  Tn554,
lasmid  pUB110  (with  the  resistance  determinants  previ-
usly  mentioned),  an  integrated  copy  of  pT181  (confers
esistance  to  tetracycline)  and  pI258  (resistance  to
ercury).27 Type  IX  and  X  SCCmec  contain  determinants
esistant  to  cadmium,  copper  and  arsenate.  Type  XI  SCCmec
ears  resistance  to  arsenate.
CCmec in CoNS
n  addition  to  the  types  and  subtypes  of  SCCmec, there  are
ariations  of  SCCmec  and  non-typeable  SCCmec observed  in
everal  studies,  mainly  in  CoNS,  which  means  that  CoNS  have
 wide  reservoir  of  SCCmec  structures.  In  the  case  of  an
CCmec  with  a  non-typeable  ccr  complex,  there  have  been
eports  of  mec  complexes  existing  even  in  the  absence  of
he  known  types  of  ccr.28,29 Moreover,  the  existence  of  new
ersions  of  recombinases  has  been  suggested,  hence  it  is  not
ossible  to  detect  them  with  the  methodology  established
or  S.  aureus.
mec  and  ccr  complexes  go  through  complex  recombining
nd  reordering  processes  in  CoNS  genomes,  through  which
he  generation  of  new  SCCmec  types  occurs.  Most  likely  just
 small  fraction  of  the  SCCmec diversity  is  present  in  S.
ureus.
SCCmec  IV  is  the  most  dominant  in  MRSA  infections
cquired  in  the  community  (CA-MRSA).30 However,  SCCmec
V  is  also  frequently  found  in  CoNS,  particularly  in  S.
pidermidis,  in  studies  of  the  community  and  hospital  envi-
onment.  In  a  report  on  hospital  isolations  of  S.  epidermidis,
6%  was  type  IV  SCCmec, 34%  type  II  SCCmec, 28%  type  III
CCmec  and  just  2%  type  I  SCCmec.31 Another  study  con-
ucted  in  healthy  patients  found  a  frequency  of  57%  of  type
V  SCCmec.14 Additionally,  other  types  of  SCCmec in  S.  epi-
ermidis  have  often  been  reported.  Such  is  the  case  of  type
II  SCCmec  which  has  been  reported  in  clinical  and  commu-
ity  isolations.31,32
Some  studies  suggest  the  transference  of  SCCmec
etween  S.  epidermidis  and  S.  aureus.31 Type  IV  SCCmec
n  S.  epidermidis  shows  a  homology  of  98--99%  with  type
V  SCCmec  in  S.  aureus. In  addition,  resistance  to  methi-
illin  is  highly  frequent  in  S.  epidermidis  isolations  and  less
requent  amongst  S.  aureus  isolations  (over  70%  of  S.  epi-
ermidis  hospital  isolations  are  resistant  to  methicillin).
ence,  it  is  possible  for  SCCmec  diversity  to  be  greater  in
.  epidermidis.31,33 In  a  study  conducted  by  Wisplinghoff
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132  
t  al.,  type  IV  SCCmec  was  highly  frequent  amongst  S.  epi-
ermidis  isolations  during  the  seventies  and  was  not  found
mong  MRSA  isolations  recovered  during  this  time.  However,
he  ﬁrst  S.  aureus  with  type  IV  SCCmec  was  recovered  dur-
ng  the  eighties.31 Type  V  SCCmec  is  also  distributed  among
oNS.34 The  characterization  of  S.  haemolyticus  SCCmec  has
roven  that  type  V  SCCmec  is  the  most  frequent  amongst  this
pecies,  even  though  there  have  also  been  reports  of  other
CCmec  structures.33,34
Nosocomial  frequency  of  methicillin-resistant  S.
aemolyticus  may  be  as  high  as  90%35,  while  also  being
esistant  to  most  antibiotics.  As  for  S.  epidermidis, from  the
ssociation  with  type  V  SCCmec  emerges  the  hypothesis  of
ransference  from  said  SCCmec  type  to  S.  aureus, which  has
een  shown  through  SCCmec  sequencing  in  both  species,
esulting  in  a  homology  superior  to  99%,  thus  making  the
ransference  between  species  possible,  which  would  involve
.  haemolyticus  as  a  reservoir  of  type  V  SCCmec.35
The  loss  of  ccr  complex  has  been  demonstrated  in  S.
aemolyticus,  which  may  contribute  to  the  resistance  phe-
otype  providing  S.  haemolyticus  the  ability  to  retain  the
esistance  to  methicillin  and  resistance  to  other  antimi-
robial  agents  contained  in  SCCmec. Additionally,  over  82
nsertion  sequences  have  been  detected  in  S.  haemolyticus,
hich  are  thought  to  provide  a  high  genomic  plasticity  to
he  species.29
It  has  been  suggested  that  class  C  mec  complex  and  ccrC
omplex  were  originated  in  S.  haemolyticus; and  that  type
 SCCmec  and  other  SCCmec  variants  were  generated  in
his  specie.  This  hypothesis  is  frequently  supported  by  the
nding  of  99%  of  nucleotide  identity  amongst  class  C  mec
omplexes  identiﬁed  in  MRSA  and  SH-MR  isolations.29,35
Barros  et  al34 reported  43%  (24  isolations)  of  S.  haemolyti-
us  isolations  as  non-typeables.  Therefore,  it  is  clear  that
he  diversity  of  elements  in  the  S.  haemolyticus  genome  is
eally  large,  thus  the  best  way  to  know  this  diversity  would
e  through  their  sequencing.
onclusions
esistance  to  methicillin  (with  the  subsequent  resistance
o  a  variety  of  pharmaceuticals)  is  a  worldwide  distribu-
ion  problem  which  occurs  in  community-related  infections
s  well  as  in  nosocomial  infections.  The  increase  in  the
requency  of  infections  caused  by  multi-resistant  microor-
anisms  makes  the  study  of  distribution  and  diversity  of
enetic  elements  which  confer  resistance  to  pharmaceut-
cals  in  bacteria  of  clinical  importance  necessary,  as  well  as
he  study  of  transmission  mechanisms  of  such  elements.
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